Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter

Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter

Aim. To evaluate the efficacy and safety of refralon (niferidil), a new class III antiarrhythmic agent whose activity is related to the block of delayed rectifying potassium current and to the prolongation of atrial and ventricular action potential and refractory periods, when it is used as an agent...

Full description

Bibliographic Details
Main Authors: E B Maĭkov, Iu A Iuricheva, N Iu Mironov, S F Sokolov, S P Golitsyn, L V Rozenshtraukh, E I Chazov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2015-01-01
Series:Терапевтический архив
Subjects:
refralon
niferidil
pharmacological cardioversion
iii class antiarrhythmic agents
atrial fibrillation
atrial flutter.
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31674

Similar Items

Similar Items